54 related articles for article (PubMed ID: 24492207)
1. Targeting host pathways to block HSV-1 at the cornea.
Kinchington PR
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):716. PubMed ID: 24492207
[No Abstract] [Full Text] [Related]
2. Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.
Alekseev O; Donovan K; Azizkhan-Clifford J
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):706-15. PubMed ID: 24370835
[TBL] [Abstract][Full Text] [Related]
3. Activation of checkpoint kinase 2 is critical for herpes simplex virus type 1 replication in corneal epithelium.
Alekseev O; Limonnik V; Donovan K; Azizkhan-Clifford J
Ophthalmic Res; 2015; 53(2):55-64. PubMed ID: 25531207
[TBL] [Abstract][Full Text] [Related]
4. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
6. Herpetic keratitis in experimental vitamin A deficiency.
Hatchell DL; O'Brien WJ; Taylor JL; Hyndiuk RA
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):238-42. PubMed ID: 8591902
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
8. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
9. A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection.
Hashizume K; Nabeshima T; Fujiwara T; Machida S; Kurosaka D
Cornea; 2009 May; 28(4):463-4. PubMed ID: 19411969
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
[TBL] [Abstract][Full Text] [Related]
11. Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply.
Nucci C; Palamara AT; Ciriolo MR; Nencioni L; Savini P; D'Agostini C; Rotilio G; Cerulli L; Garaci E
Exp Eye Res; 2000 Feb; 70(2):215-20. PubMed ID: 10655147
[TBL] [Abstract][Full Text] [Related]
12. Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene.
Zheng X; Silverman RH; Zhou A; Goto T; Kwon BS; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):120-6. PubMed ID: 11133856
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of severity of HSV-1 corneal infection by statistical pattern classification technique.
Shieh YY; Perng GC
Curr Eye Res; 2008 Mar; 33(3):225-35. PubMed ID: 18350433
[TBL] [Abstract][Full Text] [Related]
15. [In vivo observations and electron microscopy in the treatment of experimental HSV keratitis with monoclonal antibodies].
Yu J; Zhang YH; Zhang DG
Zhonghua Yan Ke Za Zhi; 1994 May; 30(3):221-4. PubMed ID: 7843007
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas.
Drolet BS; Mott KR; Lippa AM; Wechsler SL; Perng GC
Curr Eye Res; 2004; 29(2-3):181-9. PubMed ID: 15512965
[TBL] [Abstract][Full Text] [Related]
17. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1.
Tumpey TM; Elner VM; Chen SH; Oakes JE; Lausch RN
J Immunol; 1994 Sep; 153(5):2258-65. PubMed ID: 8051423
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
O'Brien WJ; Tsao LS; Taylor JL
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
[TBL] [Abstract][Full Text] [Related]
20. [Herpes simplex virus type 1 in the samples of patients with clinically prediagnosed as herpetic keratitis or keratoconjunctivitis].
Biriken D; Yildiz S; Ozkul A; Ozsan M
Mikrobiyol Bul; 2004; 38(1-2):51-9. PubMed ID: 15293902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
